论文部分内容阅读
目的:本院主要针对小儿肺炎的治疗方法进行分析。方法:本院针对小儿肺炎主要应用的药物是黄芪注射液。主要针对2009年到2011年收治的50例小儿肺炎的患者进行相应的分组治疗,将这些患儿平均分成两组,每组的患儿人数为25例,将这两组患儿命名为实验组与对照组,其中对照组患儿运用的治疗方法为常规性的对症抗感染类药物。而对照组本院主要在对症以及抗感染类的药物的基础之上,加入黄芪注射液的治疗。结果:本院在对实验组与对照组患儿的一段时间治疗之后,对其临床症状进行数据对比分析,可以明显的看出实验组的治疗效果比对照组的治疗效果好。结论:针对小儿肺炎的治疗,在其基础上运用黄芪注射液进行治疗,可以获得更好的治疗效果,所以值得推广应用。
Purpose: This hospital mainly analyzes the treatment of pediatric pneumonia. Methods: The main drug used in children with pneumonia in our hospital is astragalus injection. The main group of 50 cases of pediatric pneumonia admitted from 2009 to 2011 were divided into two groups according to the grouping. The number of children in each group was 25, and the two groups were named experimental group Compared with the control group, the control group of children with the treatment method for the conventional symptomatic anti-infectives. The control group in our hospital mainly symptomatic and anti-infective drugs based on the treatment of Astragalus injection. Results: After a period of treatment in the experimental group and the control group, the clinical data of the hospital were compared and analyzed. It can be clearly seen that the treatment effect of the experimental group is better than that of the control group. Conclusion: The treatment of pediatric pneumonia, based on the use of Astragalus injection for treatment, can get better therapeutic effect, it is worth promoting the application.